Healthcare | July 11, 2023
Bausch + Lomb acquires Blink eye drops
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Dolutegravir Tablets for Oral Suspension (RLD Tivicay PD®) had estimated annual sales of USD 1 million in the U.S. (IQVIA MAT March 2023)
Cipla has a robust governance model focused on sustainability
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
The launch of HULIO in the United States is an important milestone for Biocon Biologics
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Subscribe To Our Newsletter & Stay Updated
